 |
  
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
U.S. News Vertex: HIV Drug Not as Potent as Abbott'sJuly 25, 2003 Vertex Pharmaceuticals Inc. said that its experimental AIDS drug, GW433908, appeared less potent against HIV in a yearlong study than Abbott Laboratories' drug, Kaletra. Vertex developed the drug with GlaxoSmithKline, and the companies filed for Food and Drug Administration approval of GW433908 in December. Patients taking Kaletra had steeper reductions in HIV levels throughout the study, Vertex said. Boston Globe 07.25.03; Bloomberg News  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
 |
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
